Sensorion SA, a biotechnology company, engages in the development of novel therapies to restore, treat, and prevent hearing loss disorders in France. The company develops SENS-501, a dual AAV vector gene therapy development product for restoring hearing in patients with mutations in OTOF gene in Pha... Sensorion SA, a biotechnology company, engages in the development of novel therapies to restore, treat, and prevent hearing loss disorders in France. The company develops SENS-501, a dual AAV vector gene therapy development product for restoring hearing in patients with mutations in OTOF gene in Phase 1/2 clinical trials; and SENS-601, a candidate for the treatment of hearing loss caused by mutations of the GJB2 gene in preclinical studies. It is also developing SENS-40, a small molecule in Phase 2b clinical trials to treat sudden sensorineural hearing loss; prevention of residual hearing loss following cochlear implantation in Phase 2a clinical trials; and prevention of cisplatin-induced ototoxicity in Phase 2a clinical trials. The company was incorporated in 2009 and is headquartered in Montpellier, France. 詳細を表示
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.126 | -32.6424870466 | 0.386 | 0.394 | 0.26 | 4189543 | 0.30270897 | DE |
| 4 | -0.155 | -37.3493975904 | 0.415 | 0.4435 | 0.26 | 2058286 | 0.35940346 | DE |
| 12 | -0.352 | -57.5163398693 | 0.612 | 0.636 | 0.26 | 2587919 | 0.39066081 | DE |
| 26 | -0.09 | -25.7142857143 | 0.35 | 0.808 | 0.26 | 2866397 | 0.41911348 | DE |
| 52 | -0.13 | -33.3333333333 | 0.39 | 0.808 | 0.26 | 1659734 | 0.40818007 | DE |
| 156 | -0.076 | -22.619047619 | 0.336 | 1.04 | 0.1544 | 605621 | 0.42040249 | DE |
| 260 | -1.78 | -87.2549019608 | 2.04 | 2.29 | 0.1544 | 385637 | 0.46426486 | DE |
JimBoStevens
4分前
goodietime
8分前
janetcanada
10分前
trusttheman
10分前
beacham
17分前
asp42001
18分前
satter
19分前
BardConqueror231
22分前
KngmAz
24分前
tradeherpete
24分前
semi_infinite
26分前
Konaploinks
27分前
boston745
29分前
brazen22
32分前
Mr. Dragon
33分前
1kgwxman
33分前
boston745
34分前
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。